Companies Astrana Health, Inc.
Astrana Health (ASTH): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Astrana Health, Inc.’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers73rd pct.Of 16 peer CEOs
CEO pay, last three years
- $14,311,250FY2023
- $18,242,585FY2024
- $14,930,231FY2025
CEO total pay was $14,930,231 in fiscal 2025, down from $18,242,585 in fiscal 2024.
FY2025: salary $850,000 · bonus $0 · stock awards $11,999,980 · option awards $0
Executives and directors
Brandon Sim · CEODinesh Kumar · Chief Medical OfficerChandan Basho · CFOKenneth Sim · Executive ChairmanDavid G. Schmidt · Independent DirectorJ. Lorraine Estradas, R.N., B.S.N., M.P.H · DirectorJohn Chiang · Independent DirectorLinda Dong · DirectorMatthew Mazdyasni · Independent DirectorMitchell W. Kitayama · Lead Independent DirectorThomas S. Lam, M.D., M.P.H · DirectorWeili Dai · Independent Director
Frequently asked questions
Who was the highest-paid executive at Astrana Health, Inc. in fiscal 2025?
As disclosed, Brandon Sim (Chief Executive Officer and President) was the highest-paid executive at Astrana Health, Inc. in fiscal 2025, with total compensation of $14,930,231.
How does Astrana Health, Inc.'s chief executive pay compare to its disclosed peer group?
As disclosed, Brandon Sim's total compensation ranked at the 73rd percentile of Astrana Health, Inc.'s disclosed peer group.
What is Astrana Health, Inc.'s CEO-to-median employee pay ratio?
As disclosed, Astrana Health, Inc.'s CEO-to-median employee pay ratio was 230:1.
How did shareholders vote on Astrana Health, Inc.'s executive compensation?
As disclosed, 96.58% of shareholders supported Astrana Health, Inc.'s executive compensation in the latest say-on-pay vote.
How much does Astrana Health, Inc. spend in total on board compensation for fiscal 2025?
As disclosed, Astrana Health, Inc. reported total board compensation of $2,649,022 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Brandon Sim | $850,000 | $0 | $11,999,980 | $0 | $2,059,125 | $0 | $21,126 | $14,930,231 |
| Chief Executive Officer and President | ||||||||
| Dinesh Kumar | 700,000 | 0 | 2,199,997 | 0 | 1,356,250 | 0 | 27,468 | 4,283,715 |
| Chief Medical Officer | ||||||||
| Chandan Basho | 678,077 | 0 | 2,199,997 | 0 | 979,891 | 0 | 9,092 | 3,867,057 |
| Chief Financial Officer and Chief Operating Officer | ||||||||
| Kenneth Sim | 950,000 | 100,000 | 0 | 0 | 0 | 0 | 24,170 | 1,074,170 |
| Executive Chairman | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Brandon Sim | $14,930,231 | $18,242,585 | $14,311,250 | ↓ −3,312,354 |
| Dinesh Kumar | 4,283,715 | 10,390,830 | — | ↓ −6,107,115 |
| Chandan Basho | 3,867,057 | 5,460,490 | 5,697,506 | ↓ −1,593,433 |
| Kenneth Sim | 1,074,170 | — | — | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Compensation Committee's primary objectives in structuring and administering our executive officer compensation program are to: Attract, motivate, and retain talented and dedicated executive officers; and Reinforce business strategies and objectives for enhanced stockholder value.
| CEO STI target (% of salary) | 125% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Pearl Meyer |
| Clawback policy | True |
| Anti-hedging | True |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| Chandan Basho | RSU | 2025-03-05 | — | — | 26,701 | — | $726,000 |
| Dinesh Kumar | PSU | 2025-03-05 | 27,106 | 54,211 | — | 108,422 | 1,473,997 |
| Brandon K. Sim | PSU | 2025-03-05 | 147,848 | 295,696 | — | 591,392 | 8,039,974 |
| Dinesh Kumar | RSU | 2025-03-05 | — | — | 26,701 | — | 726,000 |
| Brandon K. Sim | RSU | 2025-03-05 | — | — | 145,642 | — | 3,960,006 |
| Chandan Basho | PSU | 2025-03-05 | 27,106 | 54,211 | — | 108,422 | 1,473,997 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| Chandan Basho | $726,000 | $1,473,997 | $0 | 67.0% |
| Dinesh Kumar | 726,000 | 1,473,997 | 0 | 67.0% |
| Brandon K. Sim | 3,960,006 | 8,039,974 | 0 | 67.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Sim | RSU | 2,779 | — | $68,947 |
| Chandan Basho | RSU | 7,214 | — | 178,979 |
| Chandan Basho | RSU | 9,695 | — | 240,533 |
| Chandan Basho | RSU | 9,809 | — | 243,361 |
| Sim | RSU | 21,492 | — | 533,217 |
| Chandan Basho | RSU | 23,364 | — | 579,661 |
| Dinesh Kumar | RSU | 23,364 | — | 579,661 |
| Sim | RSU | 27,140 | — | 673,343 |
| Sim | Option | 29,502 | 71.45 | — |
| Chandan Basho | RSU | 30,404 | — | 754,323 |
| Sim | RSU | 51,309 | — | 1,272,976 |
| Sim | RSU | 53,941 | — | 1,338,276 |
| Chandan Basho | PSU | 62,980 | — | 1,562,534 |
| Chandan Basho | PSU | 63,718 | — | 1,580,844 |
| Sim | RSU | 67,500 | — | 1,674,675 |
| Dinesh Kumar | RSU | 81,640 | — | 2,025,488 |
| Dinesh Kumar | RSU | 102,538 | — | 2,543,967 |
| Chandan Basho | PSU | 108,421 | — | 2,689,925 |
| Dinesh Kumar | PSU | 108,421 | — | 2,689,925 |
| Sim | RSU | 127,437 | — | 3,161,712 |
| Sim | PSU | 139,628 | — | 3,464,171 |
| Sim | RSU | 183,334 | — | 4,547,517 |
| Sim | PSU | 350,452 | — | 8,694,714 |
| Sim | PSU | 591,392 | — | 14,672,436 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Thomas S. Lam, M.D., M.P.HEmployee director | — | — | $0 | — | $992,530 | $992,530 |
| Mitchell W. KitayamaIndependent · Lead Independent Director · Compensation (Chair) · Nominating and Corporate Governance (Chair) | 147,504 | 169,996 | 0 | 0 | — | 317,500 |
| David G. SchmidtIndependent · Audit (Chair) · Compensation · Nominating and Corporate Governance | 125,004 | 169,996 | 0 | 0 | — | 295,000 |
| Matthew MazdyasniIndependent · Audit · Nominating and Corporate Governance | 102,000 | 169,996 | 0 | 0 | — | 271,996 |
| John ChiangIndependent · Audit · Compensation | 102,000 | 169,996 | 0 | 0 | — | 271,996 |
| Linda DongNot independent | 80,004 | 169,996 | 0 | 0 | — | 250,000 |
| Weili DaiIndependent | 80,004 | 169,996 | 0 | 0 | — | 250,000 |
| Kenneth Sim, M.DEmployee director · Board Chair | 0 | 0 | 0 | — | 0 | 0 |
| J. Lorraine Estradas, R.N., B.S.N., M.P.HNot independent | 0 | 0 | 0 | 0 | 0 | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $80,000 |
|---|---|
| Annual equity retainer | $170,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 25,000 / 20,000 / 15,000 |
| Stock ownership guideline | 3x annual cash retainer ($240,000) |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $636,516 |
| Equity awards (grant-date value) | $1,019,976 |
| All other compensation | $992,530 |
| Total cost of the board | $2,649,022 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Astrana Health as a peer
Companies that benchmark against ASTH
8 companies name ASTH as a compensation peer
- agilon health, inc.AGLFY2025
- Alignment Healthcare, Inc.ALHCFY2025
- Evolent Health, Inc.EVHFY2025
- ModivCare IncMODVFY2024
- Privia Health Group, Inc.PRVAFY2025
- Progyny, Inc.PGNYFY2025
- RadNet, Inc.RDNTFY2025
- Teladoc Health, Inc.TDOCFY2025
- U S PHYSICAL THERAPY INC /NVUSPHFY2025
Each company listed discloses ASTH in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named ASTH in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
HIMS Hims & Hers Health, Inc.OSCR Oscar Health, Inc.TDOC Teladoc Health, Inc.GDRX GoodRx Holdings, Inc.BTSG BrightSpring Health Services, Inc.ALHC Alignment Healthcare, Inc.LFST LifeStance Health Group, Inc.OPCH Option Care Health, Inc.EVH Evolent Health, Inc.CHE Chemed CorporationPRVA Privia Health Group, Inc.AGL agilon health, inc.AMED Amedisys, Inc.CLOV Clover Health Investments, Corp.DGX Quest Diagnostics IncorporatedRDNT RadNet, Inc.
Peer reciprocity
Of the companies Astrana Health, Inc. names as compensation peers, which name it back in their own disclosed peer groups. A peer set the market reciprocates reads differently from one selected in a single direction.
Hims & Hers Health, Inc. (HIMS)— Oscar Health, Inc. (OSCR)43✓ Teladoc Health, Inc. (TDOC)44— GoodRx Holdings, Inc. (GDRX)45— BrightSpring Health Services, Inc. (BTSG)46✓ Alignment Healthcare, Inc. (ALHC)47— LifeStance Health Group, Inc. (LFST)48— Option Care Health, Inc. (OPCH)49✓ Evolent Health, Inc. (EVH)50— Chemed Corporation (CHE)51✓ Privia Health Group, Inc. (PRVA)52✓ agilon health, inc. (AGL)53 Amedisys, Inc. (AMED)— Clover Health Investments, Corp. (CLOV)54— Quest Diagnostics Incorporated (DGX)55✓ RadNet, Inc. (RDNT)56
Reciprocity shown where the peer’s own current proxy has been read — each mark is cited in the register to that peer’s filing. A dash means the peer’s current proxy was read and names no reciprocal group including Astrana Health, Inc..
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | GoodRx Holdings, Inc. | 2025 | Wendy Barnes | $825,000 | $10,921,182 | $9,000,000 | $0 | $23,367,483 |
| 2 | Hims & Hers Health, Inc. | 2025 | Andrew Dudum | 494,792 | 10,635,352 | 11,000,000 | 585,763 | 22,958,907 |
| 3 | BrightSpring Health Services, Inc. | 2025 | Jon Rousseau | 1,316,717 | 6,000,015 | 5,999,997 | 3,893,750 | 17,841,460 |
| 4 | Quest Diagnostics Incorporated | 2025 | James Davis | 1,250,000 | 8,762,861 | 2,999,873 | 2,205,844 | 15,498,479 |
| 5 | Astrana Health, Inc. | 2025 | Brandon Sim | 850,000 | 11,999,980 | 0 | 2,059,125 | 14,930,231 |
| 6 | Evolent Health, Inc. | 2025 | Seth Blackley | 867,068 | 12,699,086 | 0 | 0 | 14,240,154 |
| 7 | Chemed Corporation | 2025 | Kevin McNamara | 1,858,792 | 2,883,553 | 5,036,021 | 1,486,976 | 12,904,720 |
| 8 | RadNet, Inc. | 2025 | Howard Berger | 3,000,000 | 8,999,966 | 0 | 0 | 12,087,934 |
| 9 | Alignment Healthcare, Inc. | 2025 | John Kao | 833,654 | 8,500,014 | 0 | 1,944,495 | 11,278,583 |
| 10 | Teladoc Health, Inc. | 2025 | Charles Divita, III | 800,000 | 9,699,996 | 0 | 584,000 | 11,202,996 |
| 11 | Privia Health Group, Inc. | 2025 | Parth Mehrotra | 650,000 | 8,588,373 | 0 | 1,218,750 | 10,472,698 |
| 12 | Option Care Health, Inc. | 2025 | John Rademacher | 1,000,000 | 6,500,050 | 0 | 1,665,000 | 9,266,330 |
| 13 | LifeStance Health Group, Inc. | 2025 | David Bourdon | 657,692 | 5,257,623 | 0 | 716,065 | 6,645,380 |
| 14 | agilon health, inc. | 2025 | Jeffrey Schwaneke | 625,000 | 2,950,003 | 1,750,000 | 271,875 | 5,610,878 |
| 15 | Clover Health Investments, Corp. | 2025 | Andrew Toy | 800,000 | 0 | 0 | 509,539 | 1,319,385 |
| 16 | Oscar Health, Inc. | 2025 | Mark Bertolini | 619,178 | 0 | 0 | 169,036 | 1,149,308 |
| — | Amedisys, Inc. | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Astrana Health, Inc. | 193.8% | PSU 67 · RSU 33 | No | Pearl Meyer |
| agilon health, inc. | 58% | not disclosed | No | Semler Brossy |
| Alignment Healthcare, Inc. | 200% | not disclosed | No | FW Cook |
| Amedisys, Inc. | not disclosed | not disclosed | not disclosed | not disclosed |
| BrightSpring Health Services, Inc. | not disclosed | not disclosed | not disclosed | Meridian Compensation Partners |
| Chemed Corporation | not disclosed | not disclosed | Yes — 3-Year Relative Total Shareholder Return (TSR) | Compensation Strategies, Inc. |
| Clover Health Investments, Corp. | 64% | RSU 60 · Cash LTI 40 | No | Aon, plc (Human Capital Practice) |
| Evolent Health, Inc. | 75% | PSU 70 · RSU 30 | No | Exequity |
| GoodRx Holdings, Inc. | not disclosed | not disclosed | not disclosed | Pay Governance |
| Hims & Hers Health, Inc. | 93.72% | Options 51 · RSU 49 | No | Compensia, Inc. |
| LifeStance Health Group, Inc. | not disclosed | not disclosed | not disclosed | Pay Governance |
| Option Care Health, Inc. | 111% | PSU 60 · RSU 40 | No | Pearl Meyer |
| Oscar Health, Inc. | 91.0% | RSU 50 · PSU 50 | Yes — Relative TSR | FW Cook |
| Privia Health Group, Inc. | 150% | PSU 60 · RSU 40 | No | Korn Ferry (through September 2025), WTW (starting September 2025) |
| Quest Diagnostics Incorporated | 113.9% | PSU 50 · RSU 25 · Options 25 | Yes — Relative TSR | Semler Brossy |
| RadNet, Inc. | not disclosed | RSU 100 | No | Pearl Meyer |
| Teladoc Health, Inc. | 73% | RSU 50 · PSU 50 | No | Aon |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-10 | 34,119,199 | 1,209,072 | 88,206 | 96.58% | Passed |
| 2025 | 2025-06-11 | 34,713,926 | 3,370,998 | 89,289 | 91.15% | Passed |
| 2024 | 2024-06-12 | 37,336,707 | 428,882 | 392,530 | 98.86% | Passed |
| 2023 | 2023-06-13 | 20,670,215 | 16,805,967 | 95,515 | 55.16% | Passed |
| 2022 | 2022-06-16 | 30,687,375 | 623,239 | 2,053,025 | 98.01% | Passed |
| 2016 | 2016-09-14 | 5,075,072 | 900 | 0 | 99.98% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-06-10 | 96.58%a |
| 2025 | 2025-06-11 | 91.15%b |
| 2024 | 2024-06-12 | 98.86%c |
a. Approved under the standard stated in the filing — “Abstentions and broker non-votes, if any, will have no effect on this proposal.”.
b. Approved under the standard stated in the filing — “Abstentions and broker non-votes, if any, will have no effect on this proposal.”.
c. Approved under the standard stated in the filing — “ Abstentions and broker non-votes, if any, will have no effect on this proposal.”.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 230 : 1 |
|---|---|
| CEO total compensation | $14,930,231 |
| Median employee compensation | $65,021 |
Insider trades since the proxy
No insider equity transactions reported since the proxy statement.
Sources (56 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Brandon Sim. DEF 14A, filed 2026-04-17. Section “Summary Compensation Table (“SCT”)” · page 51. As printed: 14,930,231. View filing ↗
- Section 01, Dinesh Kumar. DEF 14A, filed 2026-04-17. Section “Summary Compensation Table (“SCT”)”. As printed: 4,283,715. View filing ↗
- Section 01, Chandan Basho. DEF 14A, filed 2026-04-17. Section “Summary Compensation Table (“SCT”)”. As printed: 3,867,057. View filing ↗
- Section 01, Kenneth Sim. DEF 14A, filed 2026-04-17. Section “Summary Compensation Table (“SCT”)”. As printed: 1,074,170. View filing ↗
- Section 03, Chandan Basho RSU. DEF 14A, filed 2026-04-17. Section “EXECUTIVE COMPENSATION &” · grants of plan-based awards table. View filing ↗
- Section 03, Dinesh Kumar PSU. DEF 14A, filed 2026-04-17. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Brandon K. Sim PSU. DEF 14A, filed 2026-04-17. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
- Section 03, Dinesh Kumar RSU. DEF 14A, filed 2026-04-17. Section “EXECUTIVE COMPENSATION &” · grants of plan-based awards table. View filing ↗
- Section 03, Brandon K. Sim RSU. DEF 14A, filed 2026-04-17. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Chandan Basho PSU. DEF 14A, filed 2026-04-17. Section “Grants of Plan-Based Awards in 2025” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-17. Section “CEO Pay Ratio”. As printed: 230 : 1. View filing ↗
- Section 08, Thomas S. Lam, M.D., M.P.H. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 992,530. View filing ↗
- Section 08, Mitchell W. Kitayama. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 317,500. View filing ↗
- Section 08, David G. Schmidt. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 295,000. View filing ↗
- Section 08, Matthew Mazdyasni. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 271,996. View filing ↗
- Section 08, John Chiang. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 271,996. View filing ↗
- Section 08, Linda Dong. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 250,000. View filing ↗
- Section 08, Weili Dai. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 250,000. View filing ↗
- Section 08, Kenneth Sim, M.D. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 08, J. Lorraine Estradas, R.N., B.S.N., M.P.H. DEF 14A, filed 2026-04-17. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-06-10. Item 5.07 · say-on-pay result. As reported: 96.58% (votes for as printed: 34,119,199). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-06-11. Item 5.07 · say-on-pay result. As reported: 91.15% (votes for as printed: 34,713,926). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-06-12. Item 5.07 · say-on-pay result. As reported: 98.86% (votes for as printed: 37,336,707). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 636,516 + equity 1,019,976 + all other 992,530 = 2,649,022, summed across the director compensation table rows.
- GoodRx Holdings, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in GoodRx Holdings, Inc.'s own proxy. As printed: 23,367,483. View filing ↗
- Hims & Hers Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Hims & Hers Health, Inc.'s own proxy. As printed: 22,958,907. View filing ↗
- BrightSpring Health Services, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in BrightSpring Health Services, Inc.'s own proxy. As printed: 17,841,460. View filing ↗
- Quest Diagnostics Incorporated, Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in Quest Diagnostics Incorporated's own proxy. As printed: 15,498,479. View filing ↗
- Astrana Health, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Astrana Health, Inc.'s own proxy. As printed: 14,930,231. View filing ↗
- Evolent Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Evolent Health, Inc.'s own proxy. As printed: 14,240,154. View filing ↗
- Chemed Corporation, Section 10b CEO total. DEF 14A, filed 2026-04-09. CEO total compensation as printed in Chemed Corporation's own proxy. As printed: 12,904,720. View filing ↗
- RadNet, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-20. CEO total compensation as printed in RadNet, Inc.'s own proxy. As printed: 12,087,934. View filing ↗
- Alignment Healthcare, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Alignment Healthcare, Inc.'s own proxy. As printed: 11,278,583. View filing ↗
- Teladoc Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Teladoc Health, Inc.'s own proxy. As printed: 11,202,996. View filing ↗
- Privia Health Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-02. CEO total compensation as printed in Privia Health Group, Inc.'s own proxy. As printed: 10,472,698. View filing ↗
- Option Care Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-08. CEO total compensation as printed in Option Care Health, Inc.'s own proxy. As printed: 9,266,330. View filing ↗
- LifeStance Health Group, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in LifeStance Health Group, Inc.'s own proxy. As printed: 6,645,380. View filing ↗
- agilon health, inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in agilon health, inc.'s own proxy. As printed: 5,610,878. View filing ↗
- Clover Health Investments, Corp., Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Clover Health Investments, Corp.'s own proxy. As printed: 1,319,385. View filing ↗
- Oscar Health, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-22. CEO total compensation as printed in Oscar Health, Inc.'s own proxy. As printed: 1,149,308. View filing ↗
- Section 10a, Oscar Health, Inc. reciprocity. DEF 14A. Oscar Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Astrana Health, Inc.. View filing ↗
- Section 10a, Teladoc Health, Inc. reciprocity. DEF 14A. Teladoc Health, Inc. names Astrana Health, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, GoodRx Holdings, Inc. reciprocity. DEF 14A. GoodRx Holdings, Inc.'s most recent proxy was read; its disclosed peer group does not include Astrana Health, Inc.. View filing ↗
- Section 10a, BrightSpring Health Services, Inc. reciprocity. DEF 14A. BrightSpring Health Services, Inc.'s most recent proxy was read; its disclosed peer group does not include Astrana Health, Inc.. View filing ↗
- Section 10a, Alignment Healthcare, Inc. reciprocity. DEF 14A. Alignment Healthcare, Inc. names Astrana Health, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, LifeStance Health Group, Inc. reciprocity. DEF 14A. LifeStance Health Group, Inc.'s most recent proxy was read; its disclosed peer group does not include Astrana Health, Inc.. View filing ↗
- Section 10a, Option Care Health, Inc. reciprocity. DEF 14A. Option Care Health, Inc.'s most recent proxy was read; its disclosed peer group does not include Astrana Health, Inc.. View filing ↗
- Section 10a, Evolent Health, Inc. reciprocity. DEF 14A. Evolent Health, Inc. names Astrana Health, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Chemed Corporation reciprocity. DEF 14A. Chemed Corporation's most recent proxy was read; its disclosed peer group does not include Astrana Health, Inc.. View filing ↗
- Section 10a, Privia Health Group, Inc. reciprocity. DEF 14A. Privia Health Group, Inc. names Astrana Health, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, agilon health, inc. reciprocity. DEF 14A. agilon health, inc. names Astrana Health, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Clover Health Investments, Corp. reciprocity. DEF 14A. Clover Health Investments, Corp.'s most recent proxy was read; its disclosed peer group does not include Astrana Health, Inc.. View filing ↗
- Section 10a, Quest Diagnostics Incorporated reciprocity. DEF 14A. Quest Diagnostics Incorporated's most recent proxy was read; its disclosed peer group does not include Astrana Health, Inc.. View filing ↗
- Section 10a, RadNet, Inc. reciprocity. DEF 14A. RadNet, Inc. names Astrana Health, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗